Retatrutide Peptide | 10mg | Research Grade

Retatrutide UK availability is one of the most common research queries we receive — this page covers everything you need before ordering, including mechanism, purity testing, and storage guidance.

What Is Retatrutide?

Retatrutide is a synthetic triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously — extending the dual-agonist research approach seen in compounds like Tirzepatide with a third metabolic pathway.

ApexPure supplies Retatrutide 10mg strictly for laboratory research purposes, manufactured as a lyophilised, research-grade compound. The addition of glucagon receptor agonism alongside GIP and GLP-1 activity is the key research variable distinguishing this compound from earlier incretin-class peptides.

Research Applications

This compound is referenced in emerging metabolic research literature exploring multi-pathway energy expenditure and glucose-regulation models, extending beyond the dual-agonist research class represented by Tirzepatide. Researchers are particularly interested in whether glucagon receptor engagement contributes additional energy-expenditure effects alongside the appetite and glucose-regulation research already established for GIP/GLP-1 agonists.

Background & Research History

Retatrutide represents the latest stage in a research progression that began with single-target GLP-1 agonists, advanced to dual GIP/GLP-1 agonists like Tirzepatide, and has now extended to triple-receptor agonism. Its development reflects ongoing research interest in whether combining additional metabolic receptor pathways produces further research benefits beyond dual-agonist compounds.

Purity & Third-Party Testing

Each batch is independently HPLC-verified to a minimum of 99% purity, with a downloadable Certificate of Analysis matched to the specific batch, available on this product listing.

Reconstitution & Storage Guidelines

Keep the lyophilised vial frozen at -18°C or below, shielded from light. Once reconstituted, refrigerate at 2–8°C and avoid repeated freeze-thaw cycles to preserve this multi-mechanism compound’s stability.

Handling Notes for Researchers

Retatrutide should be handled only by qualified laboratory personnel using appropriate PPE, following institutional protocols for reconstitution, storage, and disposal. This product is not supplied for human use of any kind.

Why Buy Retatrutide UK From ApexPure

ApexPure was built around one standard: every batch we sell is independently tested before it reaches your laboratory, and every Certificate of Analysis is published, not hidden behind a support request. As one of the newest and most advanced compounds in our catalogue, Retatrutide is exactly where researchers need the most confidence in batch purity — we hold it to the same independent HPLC standard as every other ApexPure product. Orders are dispatched from the UK, so researchers avoid the customs delays and cold-chain uncertainty that come with importing from overseas suppliers. If a batch does not meet our purity threshold, it does not go on sale — that is the certification promise behind the ApexPure name. Read more about our testing process, or check our FAQ for common questions about ordering and dispatch. Our facility operates under documented quality-control procedures, with every incoming batch checked against its accompanying Certificate of Analysis before it is released into inventory. We work with independent, third-party laboratories rather than relying on internal or manufacturer-supplied test data, which is a distinction researchers increasingly look for when comparing UK suppliers. Packaging is designed to protect peptide integrity in transit, and orders are typically dispatched within one to two working days of purchase.

Frequently Asked Questions

Why is Retatrutide of research interest beyond Semaglutide and Tirzepatide?

Its additional glucagon-receptor agonism gives researchers a third metabolic pathway to study alongside GIP and GLP-1 mechanisms, extending the multi-agonist research category.

Is this compound licensed for clinical use in the UK?

No — Retatrutide is supplied by ApexPure exclusively as an unlicensed research chemical for laboratory investigation, with no therapeutic claims made.

How new is Retatrutide compared to other GLP-1 class compounds?

It represents one of the more recent developments in incretin-pathway research, building on the dual-agonist research established by earlier compounds like Tirzepatide.

This product is sold strictly for laboratory and in-vitro research use only. It is not a drug, food, supplement, or cosmetic, and is not intended for human or veterinary consumption, diagnostic, or therapeutic use. Not for use in humans or animals. Purchaser must be 18+ and confirms this material will be handled only by qualified researchers in a controlled laboratory setting, in accordance with UK law.